Ironwood Pharma (IRWD) Tops Q4 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LVS
6. SAP
7. CSX
8. LRCX
9. KNX
10. ELV

Go back to Ironwood Pharma (IRWD) Tops Q4 EPS by 7c

Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2015 Investor Update

February 18, 2016 4:05 PM EST

Key advancements within three blockbuster opportunities: IBS-C/CIC, vascular/fibrotic diseases and refractory GERD

LINZESS® (linaclotide) U.S. net sales increased ~53% to $455 million in 2015; on track to exceed $1 billion in net sales by 2020

Ironwood revenue increased >95% to $150 million in 2015, primarily driven by continued growth in LINZESS net sales and expansion in commercial margin to ~46%

Delivered on 2015 financial guidance with strong business execution

CAMBRIDGE, Mass.--(BUSINESS WIRE)--... More